FE100726
FE100726 (Compound 39) is a Cholecystokinin 2 (CCK2) receptor agonist. FE100726 has a superior binding capacity on CCK2 receptor. FE100726 can induce gastric acid secretion in anaesthetized rat models. FE100726 can be used for diabetes research[1][2].
Product Specifications
CAS Number
158459-39-3
UNSPSC
12352211
Target
Cholecystokinin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Metabolic Disease
Smiles
O=C(N(C1=CC=CC=C1C2)[C@H]2C(N([C@H](C3=CC=CC=C3)CC4)[C@H]4C(N(CC5=C(C6)C=CC=C5)[C@H]6C(N(CCC7)[C@@H]7C(O)=O)=O)=O)=O)OC(C)(C)C
Molecular Formula
C40H44N4O7
Molecular Weight
692.80
References & Citations
[1]Kalindjian SB, et al. Strategies for the design of non-peptide CCK2 receptor agonist and antagonist ligand. Curr Top Med Chem. 2007;7 (12) :1195-204. |[2]Semple G, et al. Identification and biological activity of novel peptidomimetic gastrin/CCK-B receptor agonists[J]. Bioorganic & Medicinal Chemistry Letters, 1996, 6 (24) : 2971-2976.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CCKBR
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4201602 1.0 µg DNA
Olfr1076 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
